Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 févr. 2015 08h00 HE | Source: BioSyent Inc.

BioSyent Releases Q4 and Full Year 2014 Results - Full Year Sales Up 57%; Pharma Sales Up 63%; Net Income Up 64%; Diluted EPS $0.22 Up 69%; Cash and Short-Term Investments $8.0 Million Up 82%

TORONTO, ONTARIO--(Marketwired - Feb. 25, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its Fiscal 2014 and Fourth Quarter (Q4 2014) financial results....
03 févr. 2015 08h00 HE | Source: BioSyent Inc.

BioSyent Pharma Announces the Canadian Launch of the First of 3 New Products Using the Patented Aguettant System(R)

TORONTO, ONTARIO--(Marketwired - Feb. 3, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of...
24 nov. 2014 08h00 HE | Source: BioSyent Inc.

BioSyent Pharma Launches New Proktis-M(R) Suppositories

TORONTO, ONTARIO--(Marketwired - Nov. 24, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of...
20 oct. 2014 08h00 HE | Source: BioSyent Inc.

BioSyent Releases Q3 and Nine Month Results-Q3 Sales Increase 56%, Net Income Up 64%; Nine Month Sales Up 62%, Net Income Up 75%

TORONTO, ONTARIO--(Marketwired - Oct. 20, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its Third Quarter (Q3 2014) and nine months financial results for...
21 août 2014 08h00 HE | Source: BioSyent Inc.

BioSyent Releases Q2 and Six Month Results-Q2 Sales Increase 72%, Net Income After Tax Up 112%

TORONTO, ONTARIO--(Marketwired - Aug. 21, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its Second Quarter (Q2 2014) and first half (H1 2014) financial...
23 juil. 2014 09h43 HE | Source: BioSyent Inc.

BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement For New Urgent Care Drug Product

TORONTO, ONTARIO--(Marketwired - July 23, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive...
13 juin 2014 17h12 HE | Source: BioSyent Inc.

BioSyent to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference

TORONTO, ONTARIO--(Marketwired - June 13, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that CEO René Goehrum will be making a presentation at the 2014 Bloom...
12 juin 2014 16h01 HE | Source: BioSyent Inc.

BioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 year Revenue Growth Rate of 608%

TORONTO, ONTARIO--(Marketwired - June 12, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that Canadian Business and PROFIT has ranked BioSyent as one of...
12 juin 2014 08h00 HE | Source: BioSyent Inc.

BioSyent Pharma Receives Health Canada Approval to Market New Urgent Care Product

TORONTO, ONTARIO--(Marketwired - June 12, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has received Health Canada -...
06 juin 2014 08h16 HE | Source: BioSyent Inc.

BioSyent Annual General Meeting of Shareholders - June 10, 2014

TORONTO, ONTARIO--(Marketwired - June 6, 2014) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that it will be holding its Annual General and Special Meeting of...

Page précédente